Heard at HLTH 2024: Insights from Innovative Healthcare Executives
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
Heard at HLTH 2023: Execs Share Progress on Digital Health for Pharma, Hospitals, and Behavioral Health Care Coordination
In the second part of the Heard at HLTH series, executives from BrightInsight, Iodine Software, Intelligent Medical Objects, Carrum Health, Clarify Health and Trayt Health shared new developments across their businesses and perspectives on value-based care at the HLTH 2023 event.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
Heard at HLTH: What’s on Healthcare Executives’ Agenda for 2023?
At the 5th annual HLTH conference in Las Vegas, 14 healthcare executives from companies such as Babson Diagnostics to Wheel responded to questions such as what's the difference between a positive and negative user experience in telehealth? They also previewed their plans for 2023.
BrightInsight launches new digital disease management solution for biopharma and medtech
BrightInsight developed the Disease Management Solution to help biopharma and medtech companies bring their Software as a Medical Device (SaMD) to market faster, according to BrightInsight CEO and Co-founder Dr. Kal Patel.
BrightInsight CEO Kal Patel M.D. discusses the future of regulated digital health for biopharma and medtech
In order to benefit from the Virtual1Care trend, pharma and medtech companies must ensure that their digital health tools, wrapped around a drug or device, comply with evolving regulations.
Regulated digital health explained: What you need to know to stay compliant
Digital health thought leader Mark Tarby, BrightInsight vice president of regulatory and quality management systems, shared his take on what the EU MDR means for connected devices, Software as a Medical Device (SaMD), and the go-to market strategies for the companies behind them.
presented by
Navina’s AI Copilot Eases the Value-Based Burden, Study Shows
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
General Catalyst leads $101M investment in startup helping pharma build digital health tools
BrightInsight, a startup developing infrastructure to make it easier for companies to make their own health apps, raised $101 million in funding. General Catalyst led the series C round.
AstraZeneca presses forward with digital approach to managing chronic conditions
AstraZeneca is turning to digital technology to help patients and clinicians manage the treatment of chronic diseases. Though this technology isn’t tied to any AstraZeneca drug, the company believes such digital tools will become part of the new standard of care.
How digital health impacts the development and adoption of cancer immunotherapies
In an interview, BrightInsight Co-founder and CEO Kal Patel, MD, offered a preview of the report, The Role of Digital Health in Immuno-oncology Therapy Development and Adoption.
Covid-19’s digital imperative for biopharma and medtech
The disruption to biopharma and medtech businesses caused by Covid-19, such as product launch and clinical trial delays, has underscored the need for a more digital focused strategy.
presented by
The 5 Best Medical Billing Outsourcing Companies
Medical billing is a tedious administrative task, but outsourcing it may be the key to increased revenue. Explore the top medical billing outsourcing companies and the benefits of partnering with one.
Startups talk about what it’s like to raise money in a pandemic
MedCity spoke with Evidation and BrightInsight, two startups that have recently announced funding rounds, amid a Covid-19 pandemic worsening in the U.S.
BrightInsight raises $40M to help biopharma companies create digital health tools
BrightInsight, a startup developing an IoT platform for medical device and biopharma companies, closed a $40 million series B funding round. The company recently struck two partnerships with AstraZeneca and CSL Behring.
How biopharma and medical device companies can avoid digital health regulatory pitfalls
Kal Patel, MD, CEO and co-founder of BrightInsight, highlighted the value of using a regulated Internet of Things (IoT) infrastructure to host and manage digital health products in an interview with MedCity News.
BrightInsight raises $25M for its connected health software tool
San Jose-based BrightInsight is a spin-off from contract manufacturer Flex and has raised funding for its internet-of-things platform for connected medical devices and drug delivery systems.